• Citer

New co-spray-dried tobramycin nanoparticles-clarithromycin inhaled powder systems for lung infection therapy in cystic fibrosis patients.

par Pilcer, Gabrielle ;Rosiere, Rémi ;Traina, Karl;Sebti, Thami;Vanderbist, Francis ;Amighi, Karim
Référence Journal of pharmaceutical sciences, 102, 6, page (1836-46), DOI 10.1002/jps.23525 ABSTRACT:
Publication Publié, 2013-04-09

Article révisé par les pairs

• Détails
• Contenu

Titre:	New co-spray-dried tobramycin nanoparticles-clarithromycin inhaled powder systems for lung infection therapy in cystic fibrosis patients.
Auteur:	Pilcer, Gabrielle; Rosiere, Rémi; Traina, Karl; Sebti, Thami; Vanderbist, Francis; Amighi, Karim
Informations sur la publication:	Journal of pharmaceutical sciences, 102, 6, page (1836-46), DOI 10.1002/jps.23525 ABSTRACT:
Statut de publication:	Publié, 2013-04-09
Sujet CREF:	Technologie pharmaceutique
	Sciences pharmaceutiques
Mots-clés:	Aerosol
	Antibiotic
	Clarithromycin
	Dry powder inhaler
	Formulation
	Nanoparticles
	Pulmonary drug delivery
	Spray drying
	Tobramycin
Note générale:	JOURNAL ARTICLE
	SCOPUS: ar.j
Langue:	Autre
Identificateurs:	urn:issn:0022-3549
	info:doi/10.1002/jps.23525
	info:scp/84877920804
	info:pmid/23568616